VIENNA, Austria, and CUXHAVEN, Germany, June 18 /PRNewswire/ -- EUCODIS Bioscience, a company developing, manufacturing, and marketing enzymes and other proteins for the chemical industry, announced today that it has achieved an important milestone in the development of an undisclosed protein for Lohmann Animal Health (LAH), a leading provider of feed components and vaccines for farm animals. This achievement triggered a milestone payment from LAH to EUCODIS Bioscience.
EUCODIS Bioscience is developing an innovative protein that LAH plans to use as the active ingredient of a new product line. EUCODIS Bioscience and LAH currently have two development agreements in place. In February, EUCODIS Bioscience announced the achievement of a development milestone pertaining to a separate agreement with LAH.
"We have made significant progress in developing a protein showing innovative properties that will bring significant value for agricultural applications," said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. "We are excited about this project, as the product we are developing for our partner LAH has the potential to open a new market in the food and feed industry."
About EUCODIS Bioscience
EUCODIS Bioscience GmbH develops, manufactures, and markets industrial enzymes.
EUCODIS Bioscience' products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.
EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own products.
Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional venture capital funds, founders, and private investors. The Company is headquartered in Austria, Europe, with subsidiaries in France and Germany.
For more information, please visit http://www.eucodisbioscience.com
About Lohmann Animal Health
Lohmann Animal Health (LAH) is a leading provider of feed components and vaccines for farm animals, contributing to a safe food supply. Based in Germany, LAH is active in major markets worldwide, with more than 70 percent of its revenues generated from export sales. The Company has more than 500 employees in Germany and the United States as well as in its subsidiaries and sales offices in over 30 countries.
As European market leader LAH offers a wide variety of proven and innovative products in the Feed Additives segment. They range from amino acids and antioxidants to flavors and colorants to probiotics and enzymes. LAH also offers the entire spectrum of vitamins and provitamins, including beta-carotene, as well as specialties such as L-carnitine and botanicals.
For more information, please visithttp://www.lah.de Contact Lohmann Animal Health: Dr. Roland Boerner Head of Corporate Communications Lohmann Animal Health GmbH & Co KG Heinz-Lohmann-Strasse 4 D-27472 Cuxhaven GERMANY +49-4721-747 424 Roland.Boerner@lah.de Company contact EUCODIS Bioscience: Rudy Pandjaitan, PhD CEO EUCODIS Bioscience Brunner Strasse 59 A-1230 Vienna AUSTRIA +43-1-86634-9241 email@example.com Media contact EUCODIS Bioscience: Frank Butschbacher Investor Relations & Communications http://www.butschbacher.net +43-650-7844940 firstname.lastname@example.org
|SOURCE EUCODIS Bioscience|
Copyright©2009 PR Newswire.
All rights reserved